WRIGHT Foundation CIC’s Post

If you have committed your life to improving the Quality of Life in COPD patients, this is a recent paper about the interaction between QoL and Meaning in Life (MIL) in COPD you need to familiarize yourself with: https://lnkd.in/g6JTBnBU #COPD #QoL #MayoClinic #TheBiggerPicture

Do you have any insights on this? A study on COPD that is focused on human factors and patient needs, with an aim to understand the challenges patients face in order to support the development of treatment. https://lnkd.in/eMWv8QRt #RespiratoryPC

Ema Rastoder har publiceret en artikel hos Copenhagen Respiratory Research COP RESP om koagulationen hos patienter med kronisk obstruktiv lungesygdom i rolig fase og i forbindelse med en forværring. Ema Rastoder has published an article with Copenhagen Respiratory Research COP RESP on coagulation patterns in patients with COPD during steady fase and in relation to an exacerbation. https://lnkd.in/eMnMbqis

🏔 Uncovering the Mysteries of COPD at High Altitudes 👟 Living with COPD comes with its own set of challenges, but when you add in altitude hypoxia, the game changes completely. At >2500 meters above sea level, COPD patients face a whole new level of physical fitness deterioration... Global initiatives for COPD emphasize the importance of personalized exercise programs for its treatment... But here's the twist: standard cardiopulmonary exercise tests (CPET) may prove inadequate for those living in high-altitude regions... Our recent case report delves into this issue. We followed a COPD patient residing at >2500 meters through different cardiopulmonary exercise test (CPET) protocols with a two-week gap until achieving our proposed CPET... 🏁 The goal? To establish a CPET protocol for COPD at high altitudes that allows for maximum thresholds of physical performance... 🔎 What did we discover? The minimum criteria set by the American Thoracic Society (ATS) were not met with conventional CPET protocols, and crucial cardiovascular, ventilatory, and metabolic maximals crucial for exercise prescription were not achieved. 📚 Our conclusion? It's time to adapt. CPET protocols for COPD patients need a high-altitude overhaul to truly achieve maximum thresholds... We present our proposed CPET protocol. Let's breathe new life into COPD treatment and tailor our approach to the air we breathe. #COPDInsights #HighAltitudeHealth #AdaptandThrive 🌬️🏔️ https://lnkd.in/eVZENsmD

https://lnkd.in/gUqtJfQf Can muscle wasting responsible for increase in grade of Dyspnoea in severe stage of COPD?

In our latest paper, we evaluate the impact of extrafine triple (BDP/FF/GB) and dual (BDP/FF) therapy on lung hyperinflation and exercise endurance in COPD patients. A huge thank you to the entire team for their hard work and dedication. Check out the link below 👇 #research #copd #tripletherapy https://lnkd.in/dcf2z8pU

Spirometer Market size is estimated to reach $1.4 billion by 2027, growing at a CAGR of 3.4% during the forecast period 2022-2027. ➡️ 𝑭𝒐𝒓 𝑴𝒐𝒓𝒆 𝑰𝒏𝒇𝒐𝒓𝒎𝒂𝒕𝒊𝒐𝒏 @ https://lnkd.in/ebNjbFYk Key Takeaways Geographically, North America Spirometer Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the increasing predominance of Chronic Obstructive Pulmonary Disease (COPD), Asthma, and additional respiratory diseases in the North American region. Spirometer Market growth is being driven by the rising pervasiveness of respiratory diseases like asthma and Chronic Obstructive Pulmonary Disease (COPD) across the world and the surging inclination towards home healthcare. However, the limited awareness of Chronic Obstructive Pulmonary Disease (COPD) amidst the common population resulting in the restricted application of spirometers for detection is one of the major factors hampering the growth of Spirometer Market. Spirometer Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Spirometer Market report.   ➡️𝙏𝙤 𝘽𝙪𝙮 𝙩𝙝𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 @ https://lnkd.in/eQDAhRUD   ➡️ 𝐤𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : CareFusion , Vitalograph, Nihon Kohden America MGC Diagnostics , SCHILLER AG, COSMED, Hillrom , Fukuda Sangyo Co., Ltd., Midmark Corporation, SCHILLER AG, International Medical Corps , Jones Medical , ndd Medical Technologies, Welch Allyn Geratherm Medical AG (GME) ✨ (𝐘𝐞𝐚𝐫 𝐄𝐧𝐝 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐟 𝟏𝟎𝟎𝟎$ 𝐨𝐧 𝐚𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞𝐬 | 𝐔𝐬𝐞 𝐜𝐨𝐝𝐞: 𝐅𝐋𝐀𝐓𝟏𝟎𝟎𝟎)

Respiratory Devices And Equipment (Diagnostic) Market It will grow to $11.31 billion in 2028 at a compound annual growth rate (CAGR) of 9.0% Read More @ https://lnkd.in/gSXD8MCv #marketresearchreport #marketresearch #marketintelligence #marketreport #industryanalysis #TheBusinessResearchCompany #TBRC #RespiratoryDevices

The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort https://lnkd.in/ef5mFuFz?

Fresh report reveals serious deficiencies in the care of heart patients! There are serious deficiencies in the cholesterol monitoring of heart attack survivors across Finland, according to a fresh report from the Heart Register (https://lnkd.in/dHe43RyB). Over a third of patients do not receive crucial LDL cholesterol monitoring, which may increase the risk of new heart events. Why is LDL cholesterol monitoring important? LDL cholesterol monitoring is crucial in post-heart attack care as it helps prevent new heart events. Lowering cholesterol below a certain level is one of the key goals in the treatment of coronary artery disease. What can we learn from the results? The report emphasizes the need to improve treatment practices and ensure continuity of care for heart patients. It also shows that high-quality and comprehensive data sources, such as the Heart Register, are needed to improve care and ensure its quality. How can we promote patient well-being? Patients need information and support for both lifestyle and medication adherence. Post-heart attack care must be continuous and of high quality to ensure patient well-being. Quality registers are key to improving healthcare! Quality registers, such as the Heart Register, provide valuable information about the quality of care and patient outcomes. They can help identify deficiencies and develop treatment practices to be more effective. Now is the time to make changes for better care! Through collaboration, we can ensure that heart patients receive the best possible care and support. It is essential that everyone receives the monitoring and treatment they need to promote heart health. #HeartAttack #LDLCholesterolMonitoring #HeartHealth #QualityRegisters #QualityOfCare #PatientSupport